Truck Drivers, Firefighters, and Police Officers May Have Taken More Zantac Than People In Other Occupations
High-stress occupations may have a higher propensity to cause people to eat poorly and have to take heartburn medicine
Monday, June 20, 2022 - There can be no denying that thousands of people who have developed cancer, having no family history of the disease, were taking regular dosages of Zantac heartburn and acid reflux medicine. Certain occupations like over-the-road truck drivers have a notoriously poor diet and take Zantac like they were eating candy. One woman wrote on the AboutLawsuits.com forum, "Lost my husband at age 62 in 2011 to esophageal cancer. Being an OTR truck driver and eating in truck stops he took Zantac like eating M & M's." Heartburn patients were never warned that taking the medicine could lead to developing stomach, bladder, kidney, liver, and other digestive tract cancers. People that have developed breast cancer, bladder cancer, colorectal/intestinal cancer, esophageal cancer, gastric cancer, kidney cancer, liver, lung, pancreatic, and prostate cancer, and have taken Zantac regularly for more than a year, are eligible to file a Zantac cancer lawsuit.
Zantac was once the most popular heartburn drug prescribed and over the counter to about 15 million Americans before it was recalled by the Food and Drug Administration (FDA), therefore having a coincidental diagnosis of cancer while on the drug is not out of the question. Hundreds of heartburn medicine cancer cases, however, are being filed by people with no family history of cancer and also by those that lead a healthy lifestyle and ate properly. Diabetesdaily.com wrote that salespeople, followed by administrative support personnel, firefighters, police officers, and kitchen workers like cooks, all have the highest propensity to eat poorly. Thus they are at the greatest risk of developing heartburn and have taken Zantac. More than 125,000 Zantac cancer lawsuits are registered in multidistrict litigation from around the country. The MDL is currently engaged in interviewing the expert witnesses that both sides will call when bellwether trials begin sometime as early as the first quarter of 2023. The scientific testimony against Sanofi will no doubt revolve around how ranitidine transforms into N-nitrosodimethylamine (NDMA) a deadly carcinogen given to lab rats to induce cancer tumors to be studied. Chemistry experts theorize that NDMA degrades to become NDMA when heated to a certain temperature. Sanofi claims that the tests themselves heated ranitidine samples to the extent that they degraded and that routine shipping and storage conditions and the temperatures found in the body could not produce dangerously high levels of NDMA. The FDA agrees and tested Zantac recently finding NDMA only slightly higher than the 96 NGS they had previously decided was safe. The FDA recall was due to being abundantly cautious and also because there was no way to monitor ranitidine shipping and storage conditions. Testimony will also reflect the investigation that is underway by the Department of Justice into Sanofi's prior knowledge of the science that underlies ranitidine become in NDMA. According to SPGlobal.com, "The inquiry will look into allegations that pharmaceutical manufacturers violated the False Claims Act by failing to disclose information about the potential presence of N-Nitrosodimethylamine, or NDMA, in the drug, Paris-based Sanofi noted in its half-year financial report."
More Recent Heartburn MedicineLawsuit News:
- Zantac Cancer Trials Are In Discovery To Begin In October 2022 | 7/19/2022
- Zantac Cancer Lawsuits Could Hinge On The Validity of Ranitidine Testing Methods | 7/11/2022
- Zantac Cancer Bellwether Trials In California Could Set The Stage For A Global Settlement Offer | 7/5/2022
- The FDA Recommended Protein Pump Inhibitor Drugs Like Prilosec And Nexium That May Damage Health More Than Zantac | 6/23/2022
- Scientists Are Expected To Confirm That Ranidine Causes Gastrointestinal Cancer With Slam Dunk Testimony | 6/9/2022
Lawyers for Zantac Heartburn Medicine Lawsuits
OnderLaw, LLC is a St. Louis personal injury law firm handling serious injury and death claims across the country. Its mission is the pursuit of justice, no matter how complex the case or strenuous the effort. The Onder Law Firm has represented clients throughout the United States in pharmaceutical and medical device litigation such as Pradaxa, Lexapro and Yasmin/Yaz, where the firm's attorneys held significant leadership roles in the litigation, as well as Actos, DePuy, Risperdal and others. The Onder Law Firm has won more than $300 million in four talcum powder ovarian cancer lawsuits in St. Louis. Law firms throughout the nation often seek its experience and expertise on complex litigation.